Inhibition of complement activation by soluble recombinant CR1 under conditions resembling those in a cardiopulmonary circuit: reduced up-regulation of CD11b and complete abrogation of binding of PMNs to the biomaterial surface.
暂无分享,去创建一个
B. Nilsson | K. Ekdahl | A. Larsson | U. Nilsson | G. Elgue | R. Larsson | Rolf Larsson | Anders Larsson
[1] M. Mariani,et al. Minimally invasive aortic valve replacement. , 1997, The Journal of thoracic and cardiovascular surgery.
[2] John D Lambris,et al. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library. , 1996, Journal of immunology.
[3] L. Matis,et al. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. , 1995, The Journal of clinical investigation.
[4] B. Nilsson,et al. Complement activation during cardiopulmonary bypass: effects of immobilized heparin. , 1994, The Annals of thoracic surgery.
[5] M. Pekna. Complement activation by polymethyl methacrylate (PMMA) is minimized by end-point heparin attachment , 1993 .
[6] W. Baumgartner,et al. Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.
[7] B. Nilsson,et al. Evidence for iC3 generation during cardiopulmonary bypass as the result of blood‐gas interaction , 1993, Clinical and experimental immunology.
[8] B. Nilsson,et al. Complement activation by polymethyl methacrylate minimized by end-point heparin attachment. , 1993, Biomaterials.
[9] P. Ward,et al. Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury. , 1992, Journal of immunology.
[10] T. Kinoshita,et al. Covalent binding of C3b to C4b within the classical complement pathway C5 convertase. Determination of amino acid residues involved in ester linkage formation. , 1992, The Journal of biological chemistry.
[11] B. Nilsson,et al. Generation of iC3 at the Interface between Blood and Gas , 1992, Scandinavian journal of immunology.
[12] W. Greeley,et al. Assessing the effect of cardiopulmonary bypass on the brain. , 1991, The Annals of thoracic surgery.
[13] P. Sims,et al. The response of human platelets to activated components of the complement system. , 1991, Immunology today.
[14] E. Reed,et al. Neutrophil CR3 expression and specific granule exocytosis are controlled by different signal transduction pathways. , 1991, Journal of immunology.
[15] M. Oppermann,et al. Formation of C5a during cardiopulmonary bypass: inhibition by precoating with heparin. , 1991, The Annals of thoracic surgery.
[16] M. Oppermann,et al. Inhibition of terminal complement complex formation and cell lysis by monoclonal antibodies. , 1991, Complement and inflammation.
[17] S. Thelin,et al. Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig. , 2008, Artificial organs.
[18] D. Altieri,et al. A unique recognition site mediates the interaction of fibrinogen with the leukocyte integrin Mac-1 (CD11b/CD18). , 1990, The Journal of biological chemistry.
[19] Johnson Rj. Complement activation by biomaterials. , 1990 .
[20] J. Tinker. Cardiopulmonary Bypass: Current Concepts and Controversies , 1989 .
[21] E. Fosse,et al. Different oxygenators for cardiopulmonary bypass lead to varying degrees of human complement activation in vitro. , 1989, The Journal of thoracic and cardiovascular surgery.
[22] S. Wright,et al. Transient adhesion of neutrophils to endothelium , 1989, The Journal of experimental medicine.
[23] John D Lambris,et al. Cell surface proteins reacting with activated complement components. , 1989, Complement and inflammation.
[24] H. Kozono,et al. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme. , 1988, Journal of immunology.
[25] J. Harlan,et al. Increased surface expression of CD11b/CD18 (Mac-1) is not required for stimulated neutrophil adherence to cultured endothelium. , 1988, The Journal of clinical investigation.
[26] S. Frøland,et al. Complement activation during cardiopulmonary bypass: comparison between the use of large volumes of plasma and dextran 70. , 1988, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.
[27] B. Nilsson,et al. An Assessment of the Extent of Antigenic Analogy between Physiologically Bound C3 and C3 Denatured by Sodium Dodecyl Sulphate , 1985, Scandinavian journal of immunology.
[28] S. Frøland,et al. Quantification of the Terminal Complement Complex in Human Plasma by an Enzyme‐Linked Immunosorbent Assay Based on Monoclonal Antibodies against a Neoantigen of the Complex , 1985, Scandinavian journal of immunology.
[29] J. Lambris,et al. Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes , 1982, The Journal of experimental medicine.
[30] R. Larsson,et al. Determination of platelet adhesion to polyethylene and heparinized surfaces with the aid of bioluminescence and 51chromium labelled platelets. , 1977, Thrombosis Research.
[31] H. Müller-Eberhard,et al. ISOLATION OF A FRAGMENT (C3a) OF THE THIRD COMPONENT OF HUMAN COMPLEMENT CONTAINING ANAPHYLATOXIN AND CHEMOTACTIC ACTIVITY AND DESCRIPTION OF AN ANAPHYLATOXIN INACTIVATOR OF HUMAN SERUM , 1969, The Journal of experimental medicine.